Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-025000
Filing Date
2023-04-20
Accepted
2023-04-20 16:39:37
Documents
1
Period of Report
2022-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 11773
  Complete submission text file 0001209191-23-025000.txt   13185
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37813 | Film No.: 23833647

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations